Development of Chromenopyrazole-Based Selective Cannabinoid 2 Receptor Agonists

The cannabinoid type 2 receptor (CB2R) is an important therapeutic target for pain and inflammatory disorders. G protein-coupled receptors (GPCRs) are conventionally thought to signal exclusively at the plasma membrane; however, recently this has been challenged by the notion of intracellular signal...

Full description

Saved in:
Bibliographic Details
Published in:Critical studies in media communication 2021-01, Vol.74 (6), p.433
Main Authors: Singh, Sameek, Liddle, Ian, Macdonald, Christa, Tyndall, Joel D A, Glass, Michelle, Vernall, Andrea J
Format: Article
Language:English
Subjects:
Hydrogen bonds
Ligands
Peptides
Permeability
Pharmacology
Plasma
Receptors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The cannabinoid type 2 receptor (CB2R) is an important therapeutic target for pain and inflammatory disorders. G protein-coupled receptors (GPCRs) are conventionally thought to signal exclusively at the plasma membrane; however, recently this has been challenged by the notion of intracellular signalling receptors. Better understanding of GPCR location requires tools that can differentiate cell surface versus subcellular receptors as well as accessing different parts of the body. Herein, we report the synthesis and pharmacological evaluation of polar chromenopyrazole-based CB2R-selective agonists that contain short peptides that could be useful tools for interrogating CB2R.
ISSN:1529-5036
DOI:10.1071/CH20263